|

BCMA/CD19 CAR T cells Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

  • University College, London1
  • Essen Biotech1

Indications

  • Systemic Lupus Erythematosus Acute1
  • Sjogren's Syndrome1
  • Systemic Lupus Erythematosus1
  • Lupus1
  • Autoimmune Diseases1

Other2 trials

A New Study Evaluating the Activity of Modular CAR T for mYeloma
Phase 1
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.